_20240812191253_ogImage_3.png){kind=logo}
4baseCare has raised 90 crore INR in Series B funding to scale its AI-driven OncoTwin platform and e...
The AMW Read
The article provides an incremental update on 4baseCare's expansion in the Vertical AI-Healthcare segment, specifically targeting the genomic data gap in emerging markets.
NoveltySignificance
Healthcare & Bio · Player Map
4baseCare has raised 90 crore INR in Series B funding to scale its AI-driven OncoTwin platform and expand genomics labs across emerging markets. This move directly addresses the global genomic data gap by building population-specific datasets for underrepresented groups in Asia and Latin America. Selection for the MSK iHub program validates their AI decision-support tools at a global scale. We are witnessing a systemic shift from generic oncology to data-driven precision medicine that is inclusive of all ethnicities. 🧬🌍